India's withdrawal of drug price cap guidelines to be on prospective basis

NEW DELHI, Sept 23 (Reuters) - India's decision to withdraw the drug pricing authority's powers to fix the prices of non-essential medicines will be on a prospective basis, and will not affect price caps imposed in July on 108 drugs, a senior government official said on Tuesday.